Tracheloside

Tracheloside
Product Name Tracheloside
CAS No.: 33464-71-0
Catalog No.: CFN90597
Molecular Formula: C27H34O12
Molecular Weight: 550.2 g/mol
Purity: >=98%
Type of Compound: Lignans
Physical Desc.: Powder
Targets: Estrogen receptor | Progestogen receptor
Source: The herbs of Trachelospermum jasminoides (Lindl.) Lem.
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price: $50/20mg
Tracheloside significantly decreases the activity of alkaline phosphatase (AP), an estrogen-inducible marker enzyme, with an IC(50) value of 0.31 microg/ml, a level of inhibition comparable to that of tamoxifen (IC(50) = 0.43 microg/ml).
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Plos One.2019, 15(2):e0220084
  • Histol Histopathol.2022, 18518.
  • Int J Mol Sci.2020, 21(19),7070.
  • Planta Med.2019, 85(4):347-355
  • Front. Plant Sci.2022, 13:757852.
  • bioRxiv-Pharm.&Toxi.2022, 2022.481203.
  • Food Analytical Methods2020, 1-10
  • J Mol Med (Berl).2018, 96(7):661-672
  • J of Engineering Science&Technology2018, 13(9):2820-2828
  • J Biochem Mol Toxicol.2020, 34(7):e22489.
  • Trachelogenin 4'-O-beta-gentiobioside

    Catalog No: CFN95235
    CAS No: 106647-13-6
    Price: $218/10mg
    Nortrachelogenin-8'-O-beta-glucoside

    Catalog No: CFN95234
    CAS No: 858127-38-5
    Price: $368/10mg
    Nortrachelogenin-5'-C-beta-glucoside

    Catalog No: CFN95251
    CAS No: 858127-39-6
    Price: $318/10mg
    Traxillaside

    Catalog No: CFN96608
    CAS No: 149415-62-3
    Price: Inquiry(manager@chemfaces.com)
    Trachelosiaside

    Catalog No: CFN89466
    CAS No: 106647-12-5
    Price: Inquiry(manager@chemfaces.com)
    Styraxlignolide F

    Catalog No: CFN92491
    CAS No: 823214-06-8
    Price: Inquiry(manager@chemfaces.com)
    2,3-Bis(3,4-dimethoxybenzyl)butyrolactone

    Catalog No: CFN98281
    CAS No: 25488-59-9
    Price: Inquiry(manager@chemfaces.com)
    Tupichilignan A

    Catalog No: CFN97182
    CAS No: 69586-96-5
    Price: Inquiry(manager@chemfaces.com)
    5-Acetoxymatairesinol dimethyl ether

    Catalog No: CFN97230
    CAS No: 74892-45-8
    Price: Inquiry(manager@chemfaces.com)
    Pluviatolide

    Catalog No: CFN92059
    CAS No: 28115-68-6
    Price: Inquiry(manager@chemfaces.com)
    Biosci Biotechnol Biochem. 2006 Nov;70(11):2783-5.
    An anti-estrogenic lignan glycoside, tracheloside, from seeds of Carthamus tinctorius.[Pubmed: 17090940]
    The lignan glycoside, Tracheloside, was isolated from seeds of Carthamus tinctorius (Compositae) as an anti-estrogenic principle against cultured Ishikawa cells by employing a bioassay-linked HPLC-ELSD method.
    METHODS AND RESULTS:
    Tracheloside significantly decreased the activity of alkaline phosphatase (AP), an estrogen-inducible marker enzyme, with an IC(50) value of 0.31 microg/ml, a level of inhibition comparable to that of tamoxifen (IC(50) = 0.43 microg/ml).
    Evid Based Complement Alternat Med . 2018 Jul 26;2018:4580627.
    Promotion of Keratinocyte Proliferation by Tracheloside through ERK1/2 Stimulation[Pubmed: 30147732]
    Abstract Cell migration and proliferation are important for proper wound healing after skin injury. Recent studies have shown that compounds from plants could promote cell migration and proliferation. Tracheloside, which is a plant lignan, has been found to promote the growth of HaCaT cells over 40% compared to other compounds tested based on a cell proliferation assay. An in vitro scratch assay confirmed the healing activity of Tracheloside (more than 2-fold increased healing activity after 24 hours of treatment compared with the control) and revealed that this activity is better than that of allantoin (1.2-fold increased after 24 hours of treatment compared with the control), a positive control. With western blot results, wound healing with Tracheloside occurred through the phosphorylation of ERK1/2. Therefore, Tracheloside is a good candidate to promote wound healing and could be developed as a therapeutic agent for wound treatment or used as a leading compound with higher activity.
    Cancer Lett. 2003 Oct 28;200(2):133-9.
    Lack of significant inhibitory effects of a plant lignan tracheloside on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary carcinogenesis in female Sprague-Dawley rats.[Pubmed: 14568166]
    Tracheloside, one of the plant lignans which can be extracted from the debris after safflower oil is produced from the seeds of Carthamus tinctorious, is an analogue of another plant lignan, arctiin, the side-chain C-2 of the five-membered ring being changed from a hydrogen to a hydroxyl group. We have already demonstrated that arctiin has chemopreventive effect on mammary carcinogenesis. Therefore, chemopreventive effects of Tracheloside on the initiation or post-initiation period of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary carcinogenesis in female rats were examined.
    METHODS AND RESULTS:
    For initiation, female Sprague-Dawley (SD) rats at the 6 weeks of age were given intragastric administrations of 100 mg/kg body weight of PhIP once a week for 8 weeks. The animals were treated with 0.2 or 0.02% Tracheloside during or after this carcinogen exposure. Control rats were fed basal diet with PhIP initiation or 0.2% Tracheloside or basal diet alone without initiation throughout the experimental period. All surviving animals were necropsied at the week 52 of administration. There were no clear treatment-related changes with statistical significance in all parameters for mammary carcinomas measured in this experiment.
    CONCLUSIONS:
    These results indicate that Tracheloside may not exert significant effects on PhIP-induced mammary carcinogenesis at least under the present experiment condition.
    Iristectorin A

    Catalog No: CFN95037
    CAS No: 37744-61-9
    Price: $318/20mg
    Arjungenin

    Catalog No: CFN95039
    CAS No: 58880-25-4
    Price: $318/20mg
    Quercetin 3-O-beta-(6''-p-coumaroyl)glucopyranosyl(1->2)-alpha-L-rhamnopyranoside

    Catalog No: CFN95088
    CAS No: 143061-65-8
    Price: $338/10mg
    Physalin O

    Catalog No: CFN95097
    CAS No: 120849-18-5
    Price: $413/5mg
    Isoengeletin

    Catalog No: CFN95284
    CAS No: 30987-58-7
    Price: $318/5mg
    Isomargaritene

    Catalog No: CFN95304
    CAS No: 64271-11-0
    Price: $318/10mg
    Parishin G

    Catalog No: CFN95324
    CAS No: 952283-93-1
    Price: $318/10mg
    Hydroxytyrosol 1-O-glucoside

    Catalog No: CFN95367
    CAS No: 76873-99-9
    Price: $318/10mg
    Dihydrophaseic acid 4'-O-beta-D-glucopyranoside

    Catalog No: CFN95393
    CAS No: 78914-56-4
    Price: $318/5mg
    Yakuchinone A

    Catalog No: CFN95555
    CAS No: 78954-23-1
    Price: $318/10mg